Evidence map›Paper›PMID 35187049›Full record

SynthesisFrontiers in surgery2021

Endoscopic vs. Microscopic Transsphenoidal Surgery for the Treatment of Pituitary Adenoma: A Meta-Analysis.

Jia Chen, Hongyan Liu, Siliang Man, Geng Liu, Quan Li, Qingyao Zuo, Lili Huo, Wei Li, Wei Deng

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Endoscopic and exoscopic surgery for brain tumors.International journal of clinical oncology · 2024
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jia ChenDepartment of Endocrinology, Beijing Jishuitan Hospital, Beijing, China.
Hongyan LiuDepartment of Endocrinology, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Siliang ManDepartment of Rheumatology, Beijing Jishuitan Hospital, Beijing, China.
Geng LiuDepartment of Endocrinology, Beijing Jishuitan Hospital, Beijing, China.
Quan LiDepartment of Endocrinology, Beijing Jishuitan Hospital, Beijing, China.
Qingyao ZuoDepartment of Endocrinology, Beijing Jishuitan Hospital, Beijing, China.
Lili HuoDepartment of Endocrinology, Beijing Jishuitan Hospital, Beijing, China.
Wei LiDepartment of Endocrinology, Beijing Jishuitan Hospital, Beijing, China.
Wei DengDepartment of Endocrinology, Beijing Jishuitan Hospital, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeCurrently, endoscopic transsphenoidal surgery (ETS) and microscopic transsphenoidal surgery (MTS) are commonly applied treatments for patients with pituitary adenomas. This meta-analysis was conducted to evaluate the efficacy and safety of ETS and MTS for these patients.

methodsA computer search of Pubmed, Embase, Cochrane library, Web of Science, and Google Scholar databases was conducted for studies investigating ETS and MTS for patients with pituitary adenomas. The deadline is March 01, 2021. RevMan5.1 software was used to complete this meta-analysis after literature screening, data extraction, and literature quality evaluation.

resultsA total of 37 studies including 5,591 patients were included. There was no significant difference in gross tumor removal (GTR) and hormone-excess secretion remission (HES remission) between two groups [RR = 1.10, 95% CI (0.99-1.22),

conclusionThis meta-analysis indicated that ETS cannot significantly improve GTR and HES remission. However, ETS could reduce the incidence of DI, hypothyroidism, and septal perforation without increasing the rate of other complications. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/prospero/#myprospero, identifier: CRD42021241217.

Indexed as

endoscopicmeta-analysismicroscopicpituitary adenomatranssphenoidal surgery

Identifiers

PMID35187049
PMCPMC8847202

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.